Thank you for joining us for MOASC’s “Spotlight On Clinical Oncology” series presentation by the University of California Irvine on Saturday, July 29, 2017, at the Waterfront Beach Resort, Huntington Beach. In case you were unable to attend, below is a synopsis of the event.
It was delightful to see physicians engage in deeper discussion of challenging patient cases and various treatment questions. It was encouraging to see all of the attendees taking advantage of the opportunity to network with colleagues and faculty in addition to visiting the exhibits to learn about current and upcoming products. MOASC would like to recognize and thank the following companies for their support of this meeting: Agendia, Alexion, Amgen, Astrazeneca, Celgene, Daiichi Sankyo Pharmaceuticals, Inc., Eli Lilly, EMD Serono, Merck, Pfizer, Sun Pharma, Takeda, Teva, and University of California, Irvine.
We look forward to seeing you at our next “Spotlight On Hematology” in early 2018.